Literature DB >> 22773735

An ancient founder mutation in PROKR2 impairs human reproduction.

Magdalena Avbelj Stefanija1, Marc Jeanpierre, Gerasimos P Sykiotis, Jacques Young, Richard Quinton, Ana Paula Abreu, Lacey Plummer, Margaret G Au, Ravikumar Balasubramanian, Andrew A Dwyer, Jose C Florez, Timothy Cheetham, Simon H Pearce, Radhika Purushothaman, Albert Schinzel, Michel Pugeat, Elka E Jacobson-Dickman, Svetlana Ten, Ana Claudia Latronico, James F Gusella, Catherine Dode, William F Crowley, Nelly Pitteloud.   

Abstract

Congenital gonadotropin-releasing hormone (GnRH) deficiency manifests as absent or incomplete sexual maturation and infertility. Although the disease exhibits marked locus and allelic heterogeneity, with the causal mutations being both rare and private, one causal mutation in the prokineticin receptor, PROKR2 L173R, appears unusually prevalent among GnRH-deficient patients of diverse geographic and ethnic origins. To track the genetic ancestry of PROKR2 L173R, haplotype mapping was performed in 22 unrelated patients with GnRH deficiency carrying L173R and their 30 first-degree relatives. The mutation's age was estimated using a haplotype-decay model. Thirteen subjects were informative and in all of them the mutation was present on the same ~123 kb haplotype whose population frequency is ≤10%. Thus, PROKR2 L173R represents a founder mutation whose age is estimated at approximately 9000 years. Inheritance of PROKR2 L173R-associated GnRH deficiency was complex with highly variable penetrance among carriers, influenced by additional mutations in the other PROKR2 allele (recessive inheritance) or another gene (digenicity). The paradoxical identification of an ancient founder mutation that impairs reproduction has intriguing implications for the inheritance mechanisms of PROKR2 L173R-associated GnRH deficiency and for the relevant processes of evolutionary selection, including potential selective advantages of mutation carriers in genes affecting reproduction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773735      PMCID: PMC3441126          DOI: 10.1093/hmg/dds264

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  62 in total

1.  Efficiency and power in genetic association studies.

Authors:  Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2005-10-23       Impact factor: 38.330

2.  Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.

Authors:  Catherine Dodé; Jacqueline Levilliers; Jean-Michel Dupont; Anne De Paepe; Nathalie Le Dû; Nadia Soussi-Yanicostas; Roney S Coimbra; Sedigheh Delmaghani; Sylvie Compain-Nouaille; Françoise Baverel; Christophe Pêcheux; Dominique Le Tessier; Corinne Cruaud; Marc Delpech; Frank Speleman; Stefan Vermeulen; Andrea Amalfitano; Yvan Bachelot; Philippe Bouchard; Sylvie Cabrol; Jean-Claude Carel; Henriette Delemarre-van de Waal; Barbara Goulet-Salmon; Marie-Laure Kottler; Odile Richard; Franco Sanchez-Franco; Robert Saura; Jacques Young; Christine Petit; Jean-Pierre Hardelin
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

3.  A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.

Authors:  Julie Sarfati; Anne Guiochon-Mantel; Philippe Rondard; Isabelle Arnulf; Alfons Garcia-Piñero; Slawomir Wolczynski; Sylvie Brailly-Tabard; Maud Bidet; Maria Ramos-Arroyo; Michèle Mathieu; Anne Lienhardt-Roussie; Graeme Morgan; Zinet Turki; Catherine Bremont; James Lespinasse; Hélène Du Boullay; Nathalie Chabbert-Buffet; Sébastien Jacquemont; Gérard Reach; Nicole De Talence; Paolo Tonella; Bernard Conrad; Francois Despert; Bruno Delobel; Thierry Brue; Claire Bouvattier; Sylvie Cabrol; Michel Pugeat; Arnaud Murat; Philippe Bouchard; Jean-Pierre Hardelin; Catherine Dodé; Jacques Young
Journal:  J Clin Endocrinol Metab       Date:  2009-12-18       Impact factor: 5.958

4.  Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.

Authors:  E M Costa; G Y Bedecarrats; B B Mendonca; I J Arnhold; U B Kaiser; A C Latronico
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

5.  The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism.

Authors:  Nelly Pitteloud; Frances J Hayes; Paul A Boepple; Suzzunne DeCruz; Stephanie B Seminara; David T MacLaughlin; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

6.  Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.

Authors:  Nelly Pitteloud; Richard Quinton; Simon Pearce; Taneli Raivio; James Acierno; Andrew Dwyer; Lacey Plummer; Virginia Hughes; Stephanie Seminara; Yu-Zhu Cheng; Wei-Ping Li; Gavin Maccoll; Anna V Eliseenkova; Shaun K Olsen; Omar A Ibrahimi; Frances J Hayes; Paul Boepple; Janet E Hall; Pierre Bouloux; Moosa Mohammadi; William Crowley
Journal:  J Clin Invest       Date:  2007-01-18       Impact factor: 14.808

7.  TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction.

Authors:  A Kemal Topaloglu; Frank Reimann; Metin Guclu; Ayse Serap Yalin; L Damla Kotan; Keith M Porter; Ayse Serin; Neslihan O Mungan; Joshua R Cook; Sazi Imamoglu; N Sema Akalin; Bilgin Yuksel; Stephen O'Rahilly; Robert K Semple
Journal:  Nat Genet       Date:  2008-12-11       Impact factor: 38.330

8.  Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism.

Authors:  Felecia Cerrato; Jenna Shagoury; Milena Kralickova; Andrew Dwyer; John Falardeau; Metin Ozata; Guy Van Vliet; Pierre Bouloux; Janet E Hall; Frances J Hayes; Nelly Pitteloud; Kathryn A Martin; Corrine Welt; Stephanie B Seminara
Journal:  Eur J Endocrinol       Date:  2006-11       Impact factor: 6.664

Review 9.  Phenylketonuria mutations in Europe.

Authors:  Johannes Zschocke
Journal:  Hum Mutat       Date:  2003-04       Impact factor: 4.878

10.  Loss of prokineticin receptor 2 signaling predisposes mice to torpor.

Authors:  Preeti H Jethwa; Helen I'Anson; Amy Warner; Hayden M Prosser; Michael H Hastings; Elizabeth S Maywood; Francis J P Ebling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-16       Impact factor: 3.619

View more
  11 in total

Review 1.  Discovering Genes Essential to the Hypothalamic Regulation of Human Reproduction Using a Human Disease Model: Adjusting to Life in the "-Omics" Era.

Authors:  M I Stamou; K H Cox; William F Crowley
Journal:  Endocr Rev       Date:  2015-09-22       Impact factor: 19.871

2.  Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency.

Authors:  Kimberly H Cox; Luciana M B Oliveira; Lacey Plummer; Braden Corbin; Thomas Gardella; Ravikumar Balasubramanian; William F Crowley
Journal:  Hum Mol Genet       Date:  2018-01-15       Impact factor: 6.150

3.  Mutation Spectrum of STAR and a Founder Effect of the p.Q258* in Korean Patients with Congenital Lipoid Adrenal Hyperplasia.

Authors:  Eungu Kang; Yoon-Myung Kim; Gu-Hwan Kim; Beom Hee Lee; Han-Wook Yoo; Jin-Ho Choi
Journal:  Mol Med       Date:  2017-05-02       Impact factor: 6.354

4.  Expanding the Spectrum of Founder Mutations Causing Isolated Gonadotropin-Releasing Hormone Deficiency.

Authors:  Jin-Ho Choi; Ravikumar Balasubramanian; Phil H Lee; Natalie D Shaw; Janet E Hall; Lacey Plummer; Cassandra L Buck; Marie-Laure Kottler; Katarzyna Jarzabek; Sławomir Wołczynski; Richard Quinton; Ana Claudia Latronico; Catherine Dode; Tsutomu Ogata; Hyung-Goo Kim; Lawrence C Layman; James F Gusella; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2015-07-24       Impact factor: 5.958

5.  Correlation Analysis of Genotypes and Phenotypes in Chinese Male Pediatric Patients With Congenital Hypogonadotropic Hypogonadism.

Authors:  Yi Wang; Miao Qin; Lijun Fan; Chunxiu Gong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-20       Impact factor: 6.055

Review 6.  Discovering Genes Essential to the Hypothalamic Regulation of Human Reproduction Using a Human Disease Model: Adjusting to Life in the "-Omics" Era.

Authors:  M I Stamou; K H Cox; William F Crowley
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

7.  TSHZ1-dependent gene regulation is essential for olfactory bulb development and olfaction.

Authors:  Daniela Ragancokova; Elena Rocca; Anne M M Oonk; Herbert Schulz; Elvira Rohde; Jan Bednarsch; Ilse Feenstra; Ronald J E Pennings; Hagen Wende; Alistair N Garratt
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 19.456

8.  Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort.

Authors:  Stefanie Eggers; Simon Sadedin; Jocelyn A van den Bergen; Gorjana Robevska; Thomas Ohnesorg; Jacqueline Hewitt; Luke Lambeth; Aurore Bouty; Ingrid M Knarston; Tiong Yang Tan; Fergus Cameron; George Werther; John Hutson; Michele O'Connell; Sonia R Grover; Yves Heloury; Margaret Zacharin; Philip Bergman; Chris Kimber; Justin Brown; Nathalie Webb; Matthew F Hunter; Shubha Srinivasan; Angela Titmuss; Charles F Verge; David Mowat; Grahame Smith; Janine Smith; Lisa Ewans; Carolyn Shalhoub; Patricia Crock; Chris Cowell; Gary M Leong; Makato Ono; Antony R Lafferty; Tony Huynh; Uma Visser; Catherine S Choong; Fiona McKenzie; Nicholas Pachter; Elizabeth M Thompson; Jennifer Couper; Anne Baxendale; Jozef Gecz; Benjamin J Wheeler; Craig Jefferies; Karen MacKenzie; Paul Hofman; Philippa Carter; Richard I King; Csilla Krausz; Conny M A van Ravenswaaij-Arts; Leendert Looijenga; Sten Drop; Stefan Riedl; Martine Cools; Angelika Dawson; Achmad Zulfa Juniarto; Vaman Khadilkar; Anuradha Khadilkar; Vijayalakshmi Bhatia; Vũ Chí Dũng; Irum Atta; Jamal Raza; Nguyen Thi Diem Chi; Tran Kiem Hao; Vincent Harley; Peter Koopman; Garry Warne; Sultana Faradz; Alicia Oshlack; Katie L Ayers; Andrew H Sinclair
Journal:  Genome Biol       Date:  2016-11-29       Impact factor: 13.583

9.  KLB, encoding β-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism.

Authors:  Cheng Xu; Andrea Messina; Emmanuel Somm; Hichem Miraoui; Tarja Kinnunen; James Acierno; Nicolas J Niederländer; Justine Bouilly; Andrew A Dwyer; Yisrael Sidis; Daniele Cassatella; Gerasimos P Sykiotis; Richard Quinton; Christian De Geyter; Mirjam Dirlewanger; Valérie Schwitzgebel; Trevor R Cole; Andrew A Toogood; Jeremy Mw Kirk; Lacey Plummer; Urs Albrecht; William F Crowley; Moosa Mohammadi; Manuel Tena-Sempere; Vincent Prevot; Nelly Pitteloud
Journal:  EMBO Mol Med       Date:  2017-10       Impact factor: 12.137

Review 10.  Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome: Past, Present, and Future.

Authors:  Soo Hyun Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.